Nikotin Fertin: Uses, Dosage & Side Effects
A nicotine replacement therapy (NRT) product designed to help adults quit smoking by delivering controlled doses of nicotine to reduce withdrawal symptoms and cravings
Nikotin Fertin is a nicotine replacement therapy (NRT) product available as chewing gum in 2 mg and 4 mg strengths. It is designed to help adults quit smoking by providing a controlled, lower dose of nicotine to alleviate withdrawal symptoms and reduce cigarette cravings. Nicotine replacement therapy is one of the most extensively studied and evidence-based approaches to smoking cessation, and is recommended by the World Health Organization (WHO), the European Medicines Agency (EMA), and numerous national health authorities as a first-line treatment for tobacco dependence. Nikotin Fertin delivers nicotine through the oral mucosa during chewing, offering a safer alternative to obtaining nicotine from tobacco products.
Quick Facts: Nikotin Fertin
Key Takeaways
- Nikotin Fertin is a nicotine chewing gum used as part of nicotine replacement therapy (NRT) to help adults quit smoking by reducing withdrawal symptoms and cigarette cravings.
- It is available in 2 mg (for light-to-moderate smokers) and 4 mg (for heavy smokers who smoke 20 or more cigarettes per day or smoke within 30 minutes of waking).
- The gum should be chewed slowly using the "chew and park" technique — chew until you notice a peppery or tingling taste, then park the gum between your cheek and gum to allow nicotine absorption through the oral mucosa.
- Treatment typically lasts 8 to 12 weeks with gradual dose reduction; nicotine replacement therapy approximately doubles quit rates compared to placebo according to Cochrane systematic reviews.
- Avoid eating and drinking (especially acidic beverages) for 15 minutes before and during use; common side effects include mouth irritation, hiccups, and jaw soreness, which usually improve with proper technique.
What Is Nikotin Fertin and What Is It Used For?
Nikotin Fertin belongs to a class of medications known as nicotine replacement therapies (NRTs). These therapies are designed to provide the body with nicotine in a controlled, pharmaceutical-grade form, allowing smokers to gradually wean themselves off nicotine dependence without the enormous health risks associated with continued tobacco use. Tobacco smoking remains the single largest preventable cause of death worldwide, responsible for more than 8 million deaths annually according to the World Health Organization. Of these, approximately 1.3 million are non-smokers exposed to secondhand smoke. The development of NRT products like Nikotin Fertin has been a cornerstone of public health efforts to reduce smoking prevalence globally.
The active ingredient in Nikotin Fertin is pharmaceutical-grade nicotine, which is released from the gum during chewing and absorbed through the buccal mucosa (the lining of the mouth). Unlike cigarette smoking, which delivers nicotine to the brain in a rapid bolus within 10 to 20 seconds, nicotine gum provides a slower, more gradual rise in blood nicotine levels. This steadier delivery pattern helps to reduce the intensity of withdrawal symptoms — including irritability, anxiety, difficulty concentrating, restlessness, increased appetite, and depressed mood — while avoiding the reinforcing "rush" that makes cigarettes so addictive. By partially satisfying the body’s nicotine receptors, the gum helps break the behavioral habit of smoking while managing the physiological dependence.
Nicotine itself, while addictive, is not the primary cause of smoking-related diseases. The vast majority of harm from cigarettes comes from the combustion products: tar, carbon monoxide, formaldehyde, benzene, hydrogen cyanide, and thousands of other toxic and carcinogenic chemicals generated when tobacco is burned. By delivering nicotine without combustion, Nikotin Fertin eliminates exposure to these dangerous substances. This is the fundamental principle underlying all nicotine replacement therapies and is the reason why public health organizations worldwide endorse NRT as a safe and effective smoking cessation aid.
Nikotin Fertin is indicated for the relief of nicotine withdrawal symptoms associated with quitting smoking. It is suitable for smokers who are motivated to stop smoking and is intended to be used as part of a comprehensive smoking cessation program that ideally includes behavioral support, counseling, or participation in a quit-smoking program. Research consistently shows that combining NRT with behavioral support significantly improves quit rates compared to either approach alone. The gum format offers the additional advantage of giving former smokers something to do with their hands and mouth, addressing the oral fixation component of the smoking habit.
When you quit smoking, your brain’s nicotinic acetylcholine receptors — which have become accustomed to regular nicotine stimulation — suddenly receive no nicotine. This triggers withdrawal symptoms. NRT products like Nikotin Fertin provide just enough nicotine to partially activate these receptors, preventing the worst withdrawal symptoms while you gradually reduce your dependence. Over time, the number and sensitivity of these receptors return to normal, allowing you to eventually stop NRT as well.
What Should You Know Before Taking Nikotin Fertin?
While nicotine replacement therapy is considered significantly safer than continued smoking, it is important to use Nikotin Fertin appropriately and to be aware of situations where caution is required or medical advice should be sought before starting treatment. Nicotine is a pharmacologically active substance that affects the cardiovascular and nervous systems, and certain medical conditions may require dose adjustments or additional monitoring during NRT use.
Contraindications
Nikotin Fertin should not be used by individuals who have a known hypersensitivity (allergy) to nicotine or any of the excipients in the product. Non-smokers and individuals who have never used tobacco products should not use Nikotin Fertin, as the product is designed specifically to replace nicotine obtained from tobacco. Children and adolescents under 18 years of age should generally not use NRT without explicit medical supervision, as their nicotine dependence patterns differ from adults and the safety profile in this age group is less well-established.
Warnings and Precautions
Several medical conditions warrant particular caution when considering nicotine replacement therapy. If you have any of the following conditions, you should consult your doctor or pharmacist before using Nikotin Fertin:
- Cardiovascular disease: Patients with recent myocardial infarction (heart attack), unstable or worsening angina, severe cardiac arrhythmias, or recent cerebrovascular accident (stroke) should use NRT only under close medical supervision. While NRT is generally considered safer than continued smoking even in cardiac patients, the added nicotine may affect heart rate and blood pressure.
- Peripheral vascular disease: Nicotine causes vasoconstriction (narrowing of blood vessels), which could potentially worsen symptoms in patients with peripheral arterial disease or Raynaud’s phenomenon.
- Peptic ulcer disease: Nicotine may stimulate gastric acid secretion, potentially aggravating stomach or duodenal ulcers. Swallowed nicotine from the gum may also cause gastrointestinal discomfort.
- Uncontrolled hypertension: Although NRT generally causes less cardiovascular stimulation than cigarettes, patients with poorly controlled high blood pressure should discuss the risks and benefits with their healthcare provider.
- Diabetes mellitus: Smoking cessation (with or without NRT) can alter insulin requirements. Patients with diabetes should monitor their blood sugar levels more closely during the quitting process, as reduced catecholamine release after smoking cessation may improve insulin sensitivity.
- Hepatic or renal impairment: Severe liver or kidney disease may affect the metabolism and clearance of nicotine, potentially requiring dose adjustments or closer monitoring.
- Pheochromocytoma or hyperthyroidism: These conditions may be aggravated by nicotine due to its stimulatory effects on catecholamine release and metabolic rate.
- Dental conditions: The chewing gum formulation may be problematic for individuals with temporomandibular joint (TMJ) disorders, dental prostheses, dentures, or significant dental work, as the chewing action may cause discomfort or damage dental restorations.
Pregnancy and Breastfeeding
Smoking during pregnancy is associated with serious risks to both mother and baby, including preterm birth, low birth weight, placental abruption, sudden infant death syndrome (SIDS), and long-term developmental effects. Ideally, pregnant women should quit smoking without the use of pharmacological aids. However, if non-pharmacological approaches to smoking cessation have failed, nicotine replacement therapy may be considered under medical supervision because the risk-benefit analysis generally favors NRT over continued smoking. The decision to use NRT during pregnancy should always be made in consultation with a healthcare provider who can weigh the individual circumstances.
Nicotine passes into breast milk and may affect the infant. However, the amount of nicotine and other chemicals a breastfed infant is exposed to through NRT is substantially less than through passive (secondhand) smoke exposure from a mother who continues to smoke. If a breastfeeding mother cannot quit without NRT, the use of intermittent-dosing forms like nicotine gum (rather than continuous-delivery forms like patches) is sometimes preferred, as the mother can time doses to minimize nicotine levels in breast milk during feeding. Medical advice should always be sought.
Keep all nicotine products, including used gum, out of reach of children. Nicotine is toxic in small doses for children and pets. If a child accidentally chews or swallows nicotine gum, seek emergency medical attention immediately. Symptoms of nicotine poisoning in children include nausea, vomiting, abdominal pain, diarrhea, sweating, salivation, and in severe cases, seizures, respiratory failure, and cardiovascular collapse.
How Does Nikotin Fertin Interact with Other Drugs?
An important distinction must be made between interactions caused by nicotine itself and those caused by the cessation of tobacco smoking. Many of the clinically significant drug interactions associated with quitting smoking are actually due to the absence of the polycyclic aromatic hydrocarbons (PAHs) found in tobacco smoke, which are potent inducers of the hepatic enzyme CYP1A2. When a person stops smoking, CYP1A2 activity decreases, leading to reduced metabolism and potentially increased blood levels of drugs that are substrates of this enzyme. Since NRT provides nicotine without the enzyme-inducing PAHs, these interactions occur regardless of whether or not NRT is used during the quitting process.
Nicotine itself has relatively few direct pharmacokinetic drug interactions, but it does have pharmacodynamic effects (on heart rate, blood pressure, and catecholamine release) that may interact with certain medications. Below are the most clinically relevant interactions to be aware of:
Major Interactions
| Drug | Interaction | Clinical Action |
|---|---|---|
| Theophylline | Smoking cessation reduces CYP1A2 activity, increasing theophylline levels by up to 100%. Risk of theophylline toxicity (nausea, tremor, seizures). | Monitor theophylline levels closely. Dose reduction of 25–50% may be required upon smoking cessation. |
| Warfarin | CYP1A2 induction by smoking increases warfarin metabolism. When smoking stops, warfarin levels may increase, raising the risk of bleeding. | Monitor INR frequently during and after smoking cessation. Warfarin dose reduction may be needed. |
| Insulin | Smoking reduces subcutaneous insulin absorption. Smoking cessation may improve insulin sensitivity and absorption, increasing risk of hypoglycemia. | Monitor blood glucose closely. Insulin dose may need to be reduced by 10–30% after quitting. |
| Clozapine | Clozapine is primarily metabolized by CYP1A2. Smoking cessation can increase plasma levels by 50–70%, potentially causing sedation, seizures, or agranulocytosis. | Reduce clozapine dose by approximately 30–50% and monitor plasma levels during smoking cessation. |
| Olanzapine | CYP1A2 substrate. Smoking cessation may increase olanzapine levels, leading to increased sedation and metabolic side effects. | Consider dose reduction and monitor for increased side effects after quitting smoking. |
Minor Interactions
| Drug | Interaction | Clinical Action |
|---|---|---|
| Benzodiazepines | Smoking may increase metabolism of some benzodiazepines (diazepam, chlordiazepoxide). Cessation may modestly increase sedative effects. | Monitor for increased sedation. Dose adjustments rarely needed. |
| Caffeine | CYP1A2 substrate. Smoking cessation can increase caffeine levels by up to 250%, causing jitteriness, insomnia, and palpitations. | Advise patients to reduce coffee and caffeinated beverage intake when quitting smoking. |
| Beta-blockers (propranolol) | Smoking increases propranolol clearance. Cessation may increase plasma levels and enhance blood pressure-lowering effects. | Monitor blood pressure and heart rate. Dose adjustment may be considered. |
| Tricyclic antidepressants | Imipramine and nortriptyline are partially metabolized by CYP1A2. Smoking cessation may modestly increase levels. | Monitor for increased side effects. Plasma level monitoring where available. |
Always inform your healthcare provider and pharmacist about all medications you are taking — including prescription drugs, over-the-counter medicines, herbal supplements, and vitamins — before starting Nikotin Fertin. Even if the gum itself does not directly interact with your other medications, the act of quitting smoking can significantly alter drug levels in your body. Your medication doses may need to be adjusted during and after the quitting process.
What Is the Correct Dosage of Nikotin Fertin?
The correct dosage of Nikotin Fertin depends on your level of nicotine dependence, which is most easily assessed by the number of cigarettes you smoke per day and the time to your first cigarette in the morning. These two factors are key components of the Fagerström Test for Nicotine Dependence, a validated clinical tool used to guide NRT dosing decisions. Selecting the appropriate strength is important: too low a dose may not adequately control cravings and withdrawal symptoms, potentially leading to relapse, while the goal is always to use the minimum effective dose.
Adults
| Smoking Pattern | Recommended Strength | Pieces Per Day | Duration |
|---|---|---|---|
| <20 cigarettes/day; first cigarette >30 min after waking | 2 mg | 8–12 pieces | 8–12 weeks with taper |
| ≥20 cigarettes/day; first cigarette within 30 min of waking | 4 mg | 8–12 pieces | 8–12 weeks with taper |
The "chew and park" technique is essential for proper use of nicotine gum. Chew the gum slowly until you notice a peppery, tingling, or minty taste (usually after about 15 chews). Then park the gum between your cheek and gum and leave it there until the taste or tingling fades (approximately 1 to 2 minutes). Then chew again to release more nicotine and park again. Repeat this cycle for about 30 minutes per piece. Do not chew the gum continuously like regular gum, as this causes the nicotine to be released too quickly and swallowed, leading to nausea, hiccups, and reduced absorption.
A typical treatment course follows a tapering schedule. During the first 6 weeks (phase 1), use the gum on a fixed schedule or whenever you feel the urge to smoke, typically 8 to 12 pieces per day. During weeks 7 to 9 (phase 2), reduce the number of pieces by half. During weeks 10 to 12 (phase 3), reduce further to 2 to 4 pieces per day before stopping completely. The total recommended treatment duration is usually 8 to 12 weeks, although some individuals may benefit from extended use. Most guidelines recommend not exceeding 6 months of use, but the benefits of extended NRT use almost always outweigh the risks if the alternative is a return to smoking.
Children
Nikotin Fertin is generally not recommended for children and adolescents under 18 years of age without specific medical guidance. However, in cases where adolescent smokers with established nicotine dependence are unable to quit without pharmacological support, healthcare providers may consider NRT on a case-by-case basis. The safety and efficacy data for NRT in this age group are limited, and behavioral interventions should be prioritized as the first-line approach for young smokers.
Elderly
No specific dose adjustment is generally required for elderly patients using Nikotin Fertin, as nicotine clearance is not significantly affected by age alone. However, elderly patients are more likely to have concurrent cardiovascular disease, renal impairment, or hepatic impairment that may necessitate closer monitoring. The benefits of smoking cessation in elderly patients are substantial and well-documented, including reduced risk of acute cardiovascular events, improved respiratory function, and enhanced quality of life, even in patients over 65 years of age.
Missed Dose
Nikotin Fertin is used on an as-needed basis to manage cravings rather than on a strict dosing schedule, so there is no concern about "missing a dose" in the traditional sense. If you forget to use the gum and experience strong cravings or withdrawal symptoms, simply chew a piece as soon as you remember. Do not use extra pieces to compensate. The goal is to use the minimum number of pieces needed to adequately manage withdrawal symptoms and prevent relapse.
Overdose
Nicotine overdose from gum alone is uncommon in adults, as nausea and vomiting typically limit further intake. However, overdose is possible, particularly in children, individuals who continue to smoke while using NRT, or those using multiple NRT products simultaneously without medical guidance. Symptoms of nicotine overdose include nausea, vomiting, abdominal pain, diarrhea, excessive salivation, sweating, headache, dizziness, tremor, confusion, and in severe cases, seizures, respiratory failure, and cardiovascular collapse. If overdose is suspected, seek emergency medical attention immediately. Treatment is supportive and symptomatic, as there is no specific antidote for nicotine poisoning.
Do not exceed the maximum recommended dose of 15 pieces per day. If you are using other nicotine-containing products (patches, lozenges, e-cigarettes) simultaneously, discuss the combined nicotine dose with your healthcare provider to avoid excessive nicotine exposure. Signs of too much nicotine include nausea, dizziness, rapid heartbeat, and cold sweats.
What Are the Side Effects of Nikotin Fertin?
Like all medicines, Nikotin Fertin can cause side effects, although not everybody experiences them. Many of the side effects associated with nicotine gum are related to the local effects of chewing and nicotine release in the mouth, and can be significantly reduced by using the correct "chew and park" technique. Additionally, some symptoms that occur during the quitting process (such as irritability, difficulty sleeping, or increased appetite) are actually nicotine withdrawal symptoms rather than side effects of the gum itself.
The following side effects are classified according to their frequency, based on data from clinical trials and post-marketing surveillance. Understanding the frequency helps patients and healthcare providers weigh the expected tolerability of the treatment against its benefits.
Very Common
- Mouth and throat irritation
- Hiccups
- Nausea (especially if gum is chewed too fast)
- Jaw muscle soreness from chewing
- Headache
Common
- Dizziness or lightheadedness
- Gastrointestinal discomfort (indigestion, flatulence, abdominal pain)
- Increased salivation
- Burning sensation in the mouth
- Taste disturbance (dysgeusia)
- Dry mouth
- Insomnia (difficulty sleeping)
- Palpitations (awareness of heartbeat)
Uncommon
- Skin rash or urticaria (hives)
- Flushing
- Vomiting
- Oral mucosal blistering or ulceration
- Chest discomfort
- Increased blood pressure
Rare
- Allergic reactions (angioedema, anaphylaxis)
- Cardiac arrhythmias
- Seizures (usually only with significant overdose)
- Reversible atrial fibrillation
Most side effects from nicotine gum are dose-dependent and diminish as the body adjusts to the product. Chewing too quickly is the single most common cause of local and gastrointestinal side effects, as rapid chewing releases nicotine too quickly, causing throat irritation and swallowed nicotine that irritates the stomach. Mastering the "chew and park" technique is the most effective strategy for minimizing side effects.
It is important to distinguish between side effects of the gum and symptoms of nicotine withdrawal. Common withdrawal symptoms that may occur during the quitting process include irritability, anxiety, difficulty concentrating, restlessness, increased appetite and weight gain, depressed mood, and insomnia. These withdrawal symptoms are caused by the absence of the full dose of nicotine your body was previously receiving from cigarettes, and they typically peak in the first 1 to 3 days after quitting and gradually improve over 2 to 4 weeks.
Contact your healthcare provider if you experience persistent chest pain, irregular heartbeat, signs of a severe allergic reaction (difficulty breathing, swelling of the face, lips, tongue, or throat), or any side effects that are severe, persistent, or concerning. While serious side effects from nicotine gum are rare, it is always better to seek medical advice if you are unsure.
How Should You Store Nikotin Fertin?
Proper storage of Nikotin Fertin ensures the product maintains its efficacy and safety throughout its shelf life. Nicotine is sensitive to environmental conditions, and improper storage can lead to degradation of the active ingredient, reducing the therapeutic effectiveness of the gum.
Store the gum at room temperature, ideally below 25°C (77°F). Avoid exposing the product to excessive heat (such as leaving it in a car during summer), direct sunlight, or high humidity. Keep the gum in its original blister packaging until ready to use, as this provides optimal protection against moisture and light exposure. Do not transfer the gum to other containers that may not provide adequate protection.
It is critically important to keep all nicotine products out of the sight and reach of children. Even used pieces of nicotine gum contain residual nicotine that can be toxic to children if chewed or swallowed. Dispose of used gum by wrapping it in paper or the original blister packaging and placing it in a waste container that children cannot access. Do not leave used gum in ashtrays, on tables, or in other locations where children or pets could find it.
Do not use Nikotin Fertin after the expiry date stated on the packaging (usually printed as EXP followed by month and year). The expiry date refers to the last day of that month. If you notice any changes in the appearance, taste, or texture of the gum, do not use it and consult your pharmacist. Do not dispose of medications in wastewater or household waste; ask your pharmacist about proper disposal methods to help protect the environment.
What Does Nikotin Fertin Contain?
Each piece of Nikotin Fertin chewing gum contains either 2 mg or 4 mg of nicotine as the active substance. The nicotine is bound to an ion-exchange resin (nicotine polacrilex or a similar complex) within the gum base, which allows for controlled release of nicotine during chewing. This binding mechanism is essential for the "chew and park" dosing technique, as it ensures that nicotine is released gradually during the chewing phase and can be absorbed through the buccal mucosa during the parking phase.
The inactive ingredients (excipients) in nicotine chewing gum typically include:
- Gum base: Provides the chewable matrix that holds the nicotine-resin complex and gives the product its gum-like consistency.
- Sweeteners: Such as xylitol, sorbitol, acesulfame potassium, or sucralose, to improve the taste of the product. Many NRT gums are sugar-free to minimize dental caries risk.
- Flavoring agents: Added to improve palatability and mask the naturally bitter taste of nicotine. Common flavors include mint, fruit, or unflavored varieties.
- Sodium carbonate or sodium bicarbonate: Used as buffering agents to maintain a slightly alkaline pH in the mouth, which enhances nicotine absorption through the buccal mucosa (nicotine is better absorbed in its un-ionized form at higher pH).
- Coating agents: The exterior coating may contain various inactive ingredients for improved texture, appearance, and shelf stability.
Individuals with known allergies or sensitivities to any of the excipients listed on the product packaging should review the full list of ingredients before use. If you have phenylketonuria (PKU), check whether the product contains aspartame. If you have diabetes or follow a sugar-controlled diet, note that many nicotine gum formulations are sugar-free but may contain sugar alcohols (such as sorbitol or xylitol) that have minimal impact on blood sugar levels but may cause gastrointestinal symptoms in large amounts.
Frequently Asked Questions About Nikotin Fertin
Nikotin Fertin delivers a controlled dose of nicotine through the oral mucosa when chewed, reducing withdrawal symptoms and cravings that make quitting smoking difficult. By replacing the nicotine from cigarettes without the harmful tar, carbon monoxide, and thousands of toxic chemicals in tobacco smoke, it allows smokers to gradually reduce their nicotine dependence in a safer way. Clinical studies show that nicotine replacement therapy approximately doubles quit rates compared to placebo. The gum format also addresses the oral fixation and hand-to-mouth habit that many smokers find particularly difficult to break.
Nicotine replacement therapy during pregnancy should only be used after careful medical consultation. Nicotine can affect the developing fetus by impacting blood flow to the placenta. However, if a pregnant woman cannot quit smoking without NRT, a healthcare provider may recommend it because continued smoking is generally considered more harmful than using NRT alone. The decision should always be made on an individual basis with professional medical guidance, weighing the substantial risks of continued smoking against the risks of nicotine exposure from NRT.
A typical treatment course with Nikotin Fertin lasts 8 to 12 weeks. During the first 6 weeks, you use the gum regularly whenever you feel the urge to smoke. After that, you gradually reduce the number of pieces per day over the next 2 to 6 weeks. Most guidelines recommend not exceeding 6 months of use, though some patients may benefit from longer treatment, and extended use is far safer than relapsing to smoking. Always follow your healthcare provider’s specific recommendations for your individual quit plan.
The 2 mg strength is recommended for light to moderate smokers (those who smoke fewer than 20 cigarettes per day or who smoke their first cigarette more than 30 minutes after waking). The 4 mg strength is intended for heavy smokers (those who smoke 20 or more cigarettes per day or who smoke their first cigarette within 30 minutes of waking). The higher strength provides more nicotine per piece to adequately manage withdrawal symptoms in heavily dependent smokers who have a greater physiological need for nicotine.
You should avoid eating and drinking for 15 minutes before and during chewing Nikotin Fertin. Acidic beverages such as coffee, juice, and carbonated drinks lower the pH in the mouth, which reduces nicotine absorption through the oral mucosa and makes the gum less effective. Water is generally acceptable. The gum should always be chewed slowly using the "chew and park" technique rather than chewed continuously like regular gum, as rapid chewing causes nicotine to be swallowed rather than absorbed through the mouth lining.
The most common side effects include mouth and throat irritation, hiccups, jaw soreness from chewing, nausea, and headache. These side effects are usually mild and often improve as you become accustomed to the product and master the proper chewing technique. Many gastrointestinal side effects (nausea, hiccups, heartburn) are caused by swallowing nicotine due to chewing the gum too fast. Using the "chew and park" method significantly reduces these problems. If side effects persist or are bothersome, consult your healthcare provider.
References
- Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews. 2018;5(5):CD000146. doi:10.1002/14651858.CD000146.pub5
- World Health Organization. WHO Report on the Global Tobacco Epidemic, 2023. Geneva: WHO; 2023.
- Benowitz NL. Nicotine addiction. New England Journal of Medicine. 2010;362(24):2295-2303. doi:10.1056/NEJMra0809890
- European Medicines Agency. Nicotine replacement therapy – Summary of Product Characteristics (SmPC). EMA; 2023.
- National Institute for Health and Care Excellence (NICE). Tobacco: preventing uptake, promoting quitting and treating dependence. NICE guideline [NG209]. Updated 2023.
- U.S. Food and Drug Administration. FDA Drug Safety Communication: Over-the-counter nicotine replacement therapy products. FDA; 2023.
- Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews. 2013;5:CD009329. doi:10.1002/14651858.CD009329.pub2
- Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2012;11:CD000146.
- Zevin S, Benowitz NL. Drug interactions with tobacco smoking: an update. Clinical Pharmacokinetics. 1999;36(6):425-438.
- Claire R, Chamberlain C, Davey MA, et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews. 2020;3(3):CD010078. doi:10.1002/14651858.CD010078.pub3
Editorial Team
Medical Content
Written by iMedic Medical Editorial Team – Clinical Pharmacology and Addiction Medicine specialists
Medical Review
Reviewed by iMedic Medical Review Board according to international guidelines (WHO, EMA, FDA, NICE)
Evidence Level
Level 1A – Based on systematic reviews and meta-analyses of randomized controlled trials (Cochrane)
Last Updated
– Reviewed for current guideline adherence
All iMedic content is independently produced with no pharmaceutical company sponsorship or advertising. Our editorial process follows the GRADE evidence framework and content is reviewed by board-certified physicians. For questions about our editorial process, see our editorial standards.